AFLAC Inc., US0010551028

JPMorgan raises target for Aflac stock to USD 119.00

Published on 10/16/2026 at 15:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Aflac releases third-quarter results on November 4, 2026. Aflac stock costs EUR 105.38 on October 16, 2026, up 0.59 percent on the day on Nasdaq.

Analyst view before results

  • On October 15, 2026, JPMorgan raised its Aflac target from USD 116.00 to USD 119.00.
  • Aflac will release third-quarter results on November 4, 2026.
  • Aflac stock costs EUR 105.38 at Lang & Schwarz on October 16, 2026 at 3:30 p.m. CEST, 0.59 percent above the prior close on Nasdaq of October 15, 2026.
  • Aflac had a USD 59.6 billion market capitalization and a 12.72 P/E ratio as of October 16, 2026.
AFLAC Inc. macro photography of insurance contract signature section close-up detail, ISIN US0010551028 policy documentation, Illustration mit AI erstellt.

Aflac stock had a new JPMorgan target of USD 119.00 on October 15, 2026, up from USD 116.00, putting the target 0.21 percent above the USD 118.75 home-market price. MarketBeat reported that JPMorgan kept a neutral rating while raising the target. Aflac was at EUR 105.38 at Lang & Schwarz on October 16, 2026 at 3:30 p.m. CEST, up 0.59 percent on Nasdaq versus the prior close.

Results date arrives November 4

Aflac will release its third-quarter 2026 financial results after the market closes on November 4, 2026, followed by a webcast on November 5. The company announced the schedule in a September 30 release carried on its investor website. Aflac said the webcast will begin at 8:00 a.m. ET on November 5.

Aflac price position

The latest home-market quote was USD 118.75 on the NYSE at 9:31 a.m. ET on October 16, 2026, compared with USD 118.05 at the prior close. Aflac's 52-week range was USD 105.43 to USD 130.22, placing the current home-market price 8.80 percent below the high and 12.64 percent above the low. The finance quote showed 119,796 shares traded against an average volume of 2,040,801.

Aflac's second-quarter 2026 revenue was USD 4.22 billion and earnings per share were USD 1.75, below the USD 1.76 consensus, while revenue exceeded the USD 4.11 billion estimate. Zolmax reported that second-quarter revenue declined 1.00 percent year over year.

Aflac valuation and peers

Aflac's market capitalization was USD 59.6 billion, its P/E ratio was 12.72 and its dividend yield was 2.00 percent as of October 16, 2026. The valuation sits between Prudential Financial's P/E ratio of 10.47 and MetLife's 19.41.

Comparison with peers

Aflac Incorporated (NYSE, USD): plus 0.59 percent, P/E 12.72, market capitalization USD 59.6 billion

Prudential Financial (NYSE, USD): minus 0.90 percent, P/E 10.47, market capitalization USD 39.8 billion

MetLife (NYSE, USD): plus 0.68 percent, P/E 19.41, market capitalization USD 64.2 billion

The trading picture

For investors, the next scheduled report provides the clearest dated checkpoint, while the current valuation remains below the 52-week high and above the low. The European quote and the US listing therefore present the same session in different currencies and venues.

The further course of trading is shown by the continuously updated real-time quote of Aflac stock.

Aflac market data

  • Company: Aflac Incorporated
  • ISIN: US0010551028
  • Ticker: AFL
  • Primary exchange: NYSE
  • Price Lang & Schwarz (as of October 16, 2026, 3:30 p.m. CEST): EUR 105.38
  • Change on Nasdaq versus prior close: plus 0.59 percent
  • Market capitalization: USD 59.6 billion (as of October 16, 2026)
  • 52-week range: USD 105.43-130.22 (as of October 16, 2026)
  • Sector / Industry: Financial Services / Insurance - Life
  • Next earnings date: November 4, 2026

Market context: Market report S&P 500.

More news and analyses on Aflac stock

Disclaimer...
en | US0010551028 | AFLAC INC. | boerse | 70340733 | bgmi